Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,663 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the Management of Aspirin-induced Gastrointestinal Complications (MAGIC) study.
Uchiyama S, Goto S, Origasa H, Uemura N, Sugano K, Hiraishi H, Shimada K, Okada Y, Ikeda Y; MAGIC Study Group. Uchiyama S, et al. Among authors: goto s. Heart Vessels. 2020 Feb;35(2):170-176. doi: 10.1007/s00380-019-01484-0. Epub 2019 Aug 24. Heart Vessels. 2020. PMID: 31446462 Free PMC article.
One-year cardiovascular event rates in outpatients with atherothrombosis.
Steg PG, Bhatt DL, Wilson PW, D'Agostino R Sr, Ohman EM, Röther J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S; REACH Registry Investigators. Steg PG, et al. Among authors: goto s. JAMA. 2007 Mar 21;297(11):1197-206. doi: 10.1001/jama.297.11.1197. JAMA. 2007. PMID: 17374814
Risk factor profiles of stroke, myocardial infarction, and atrial fibrillation: a Japanese Multicenter Cooperative Registry.
Uchiyama S, Shibata Y, Hirabayashi T, Mihara B, Hamashige N, Kitagawa K, Goto S, Origasa H, Shimada K, Kobayashi H, Isozaki M, Ikeda Y; J-TRACE Investigators. Uchiyama S, et al. Among authors: goto s. J Stroke Cerebrovasc Dis. 2010 May;19(3):190-197. doi: 10.1016/j.jstrokecerebrovasdis.2009.04.004. J Stroke Cerebrovasc Dis. 2010. PMID: 20434045
Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease.
Goto S, Ogawa H, Takeuchi M, Flather MD, Bhatt DL; J-LANCELOT (Japanese-Lesson from Antagonizing the Cellular Effect of Thrombin) Investigators. Goto S, et al. Eur Heart J. 2010 Nov;31(21):2601-13. doi: 10.1093/eurheartj/ehq320. Epub 2010 Aug 30. Eur Heart J. 2010. PMID: 20805115 Free PMC article. Clinical Trial.
Panel discussion.
Shigematsu H, Uchiyama S, Goto S. Shigematsu H, et al. Among authors: goto s. Drugs. 2010 Nov 1;70 Suppl 1:15-22. doi: 10.2165/00000006-000000000-00000. Drugs. 2010. PMID: 20977288 English, Japanese. No abstract available.
One-year cardiovascular event rates in Japanese outpatients with myocardial infarction, stroke, and atrial fibrillation. -Results From the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE).-.
Goto S, Ikeda Y, Shimada K, Uchiyama S, Origasa H, Kobayashi H; J-TRACE Investigators. Goto S, et al. Circ J. 2011;75(11):2598-604. doi: 10.1253/circj.cj-11-0378. Epub 2011 Aug 20. Circ J. 2011. PMID: 21857143 Free article. Clinical Trial.
One-year atherothrombotic vascular events rates in outpatients with recent non-cardioembolic ischemic stroke: the EVEREST (Effective Vascular Event REduction after STroke) registry.
Suzuki N, Sato M, Houkin K, Terayama Y, Uchiyama S, Daida H, Shigematsu H, Goto S, Tanaka K, Origasa H, Miyamoto S, Minematsu K, Matsumoto M, Okada Y. Suzuki N, et al. Among authors: goto s. J Stroke Cerebrovasc Dis. 2012 May;21(4):245-53. doi: 10.1016/j.jstrokecerebrovasdis.2012.01.010. Epub 2012 Feb 24. J Stroke Cerebrovasc Dis. 2012. PMID: 22365283
3,663 results